Cornell

The university is arguing that the judge had no basis to compel arbitration of what Cornell is claiming is a fraudulent settlement.

Cornell claims that it was fraudulently induced into settling a patent-infringement lawsuit it filed with Life Tech against Illumina.

The consortium aims to identify tuberculosis protein targets and corresponding small molecule inhibitors that can be used to develop drugs to shorten therapy duration.

This Week in PLOS

In PLOS this week: plague patterns in Kyrgyzstan, trypanosomiasis susceptibility variants, and more.

Among the winners are a number of investigators who will receive funding to support omics-focused research.

The funding will support three research centers and a data management and coordinating center investigating myalgic encephalomyelitis/chronic fatigue syndrome.

The university's new court documents allege that Life Tech, its co-plaintiff in the previous suit, "fraudulently" induced it to settle the case against Illumina.

Eyes on the Moths

Genetically modified diamondback moths are being tested in upstate New York, according to the Atlantic.

The Apple's Journey

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Pages

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.